Home/Filings/4/0001179110-13-016129
4//SEC Filing

KYTHERA BIOPHARMACEUTICALS INC 4

Accession 0001179110-13-016129

CIK 0001436304operating

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 1:00 PM ET

Size

14.0 KB

Accession

0001179110-13-016129

Insider Transaction Report

Form 4
Period: 2013-11-01
Webster Jeffrey D
Senior VP, Operations
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-11-011,90062,761 total
    Exercise: $0.76Exp: 2017-03-13Common Stock (1,900 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-11-012,10064,661 total
    Exercise: $0.76Exp: 2017-03-13Common Stock (2,100 underlying)
  • Sale

    Common Stock

    2013-11-01$44.56/sh2,100$93,5690 total
  • Exercise/Conversion

    Common Stock

    2013-11-01$0.76/sh+2,100$1,5962,100 total
  • Exercise/Conversion

    Common Stock

    2013-11-01$0.76/sh+1,900$1,4441,900 total
  • Sale

    Common Stock

    2013-11-01$45.29/sh1,900$86,0460 total
Footnotes (4)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2014.
  • [F2]100% of the shares subject to the option are fully vested and exercisable.
  • [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $44.15 to $45.00, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.015 to $45.5633, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Issuer

KYTHERA BIOPHARMACEUTICALS INC

CIK 0001436304

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001436304

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 1:00 PM ET
Size
14.0 KB